Enhancing T-cell recruitment in renal cell carcinoma with cytokine-armed adenoviruses
Michaela Feodoroff(University of Helsinki), Vincenzo Cerullo(University of Helsinki)
Cited by 11
Related Papers
Novel oncolytic adenovirus expressing enhanced cross-hybrid IgGA Fc PD-L1 inhibitor activates multiple immune effector populations leading to enhanced tumor killing in vitro, in vivo and with patient-derived tumor organoids
|Journal for ImmunoTherapy of Cancer|2021|53
CD40 ligand and tdTomato-armed vaccinia virus for induction of antitumor immune response and tumor imaging
|Gene Therapy|2013|42
Low-dose decitabine enhances the efficacy of viral cancer vaccines for immunotherapy
|Molecular Therapy Oncology|2024|6
Leveraging glucan-induced trained immunity for the epigenetic and metabolic rewiring of macrophages to enhance colorectal cancer vaccine response
|Nature Communications|2026|4
Site-Dependent Decoupling of Drug-Biomarker Associations in Clear Cell Renal Cell Carcinoma Revealed by Functional Profiling of Patient-Derived Cell Models
|bioRxiv (Cold Spring Harbor Laboratory)|2026|0